Singapore

Econ Healthcare to book $3.4m loss in Crosstec exit

The loss will not have any material impact on the company.

Econ Healthcare to book $3.4m loss in Crosstec exit

The loss will not have any material impact on the company.

SG acquires AstraZeneca's Evusheld

Evusheld is a long-acting antibody candidate for COVID-19 treatment.

Hilleman Laboratories invests $80m in vaccine development hub

The new facility is the first of its kind in Singapore.

NSG BioLabs doubles capacity with new site

The expansion aims to facilitate the growth of promising biotech companies.

AstraZeneca SG signs MOU with tech partners

The partnerships aim to improve care delivery and patient outcomes.

SMART AMR develops first-of-its-kind 10-minute COVID immunity test

The new point-of-care test offers an accuracy rate of up to 93%.

Labcorp adds 90 additional research and engineering jobs

This came as the life sciences company opened its new bioanalytical laboratory.

SingHealth and SGInnovate partner to ramp up health science innovations

Artificial intelligence in healthcare will be the first area of focus.

Singapore-developed dementia screening tool goes global

The VCAT addresses the challenges of dementia screening in multi-lingual countries.

From accidental to essential — How PairX Bio revolutionises cancer immunotherapies

The startup focuses its efforts on cancer treatment by targeting shared tumour antigens.

SG can ramp up ICU capacity but lacks people: Puthucheary

The minister addressed the Parliament about intensive care units and hospital capacity.

SingHealth Duke-NUS invests in 'the seeds of the future generation'

It launched a new institute that opens doors for maternal-child care research.

MCHRI enters partnership with Menarini Biomarkers

The two will create a regional and international hub for non-invasive diagnostics in Singapore.

SingHealth Duke-NUS opens MCHRI

The institute aims to serve as a maternal and child health research centre.

Greater Houston Healthconnect Uses InterSystems HealthShare® to Create Largest Known COVID-19 Outcomes Study

GHH has assembled a cohort of more than one million COVID-19 positive cases with all associated medical histories for outcomes analysis.

'Sandwich generation' most impacted by COVID-19 crisis: Prudential

They are the 35- to 54-year-old adults caring for both parents and children.